zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2013-10-3-2zdor-1390Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ: ЭТАПЫ ЛЕЧЕБНО-ДИАГНОСТИЧЕСКИХ МЕРОПРИЯТИЙ (обзор литературы)ATRIAL FIBRILLATION: THE STAGES OF TREATMENT AND DIAGNOSTIC MEASURES (literature review)СаливончикД. П.SalivonchykD. P.noemail@neicon.ruГомельский государственный медицинский университетGomel State Medical University201328092013031421Copyright © Саливончик Д.П., 20132013Саливончик Д.П.Salivonchyk D.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/1390

Поэтапное ведение пациента с фибрилляцией предсердий позволяет адекватно оценить тяжесть состояния больного, оценить вероятный риск развития кардиоэмболического инсульта, восстановить синусовый ритм либо добиться контроля частоты желудочковых сокращений при сохраняющейся постоянной форме ФП. Препаратом выбора при терапии ФП для предупреждения кардиоваскулярного инсульта по шкалам CHADS2 и CHA2DS2-VASc является варфарином под контролем МНО (2,0-3,0).

The stage-to-stage care after an AF patient can adequately assess the severity of the patient`s state, to assess the possible risk of cardioembolic stroke, to restore sinus rhythm or to obtain control of ventricular rate in the permanent form of persistent AF. Warfarin under the control of INR (2.0-3.0) is a drug to prevent cardiovascular stroke according to the scales CHADS2 and CHA2DS2-VASc in AF treatment.

фибрилляция предсердийконтроль ритмаконтроль ЧССварфаринМНОatrial fibrillationrhythm controlrate controlwarfarinINRReferencesКлинические рекомендации по диагностике и лечению пациентов с фибрилляцией предсердий / Р. Г. Оганов [и др.] // Вестник аритмологии. - 2010. - № 59. - С. 53-57.Клинические рекомендации по диагностике и лечению пациентов с фибрилляцией предсердий / Р. Г. Оганов [и др.] // Вестник аритмологии. - 2010. - № 59. - С. 53-57.Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation / R. Nieuwlaat [et al.] // Eur. Heart J. - 2005. - Vol. 26. - P. 2422-2434.Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation / R. Nieuwlaat [et al.] // Eur. Heart J. - 2005. - Vol. 26. - P. 2422-2434.The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management / M. Nabauer [et al.] // Europace. - 2009. - Vol. 11. - P. 423-434.The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management / M. Nabauer [et al.] // Europace. - 2009. - Vol. 11. - P. 423-434.Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) / A. J. Camm [et al.] // Eur. Heart J. - 2010. - Vol. 31. - P. 2369-2429.Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) / A. J. Camm [et al.] // Eur. Heart J. - 2010. - Vol. 31. - P. 2369-2429.ACCF/AHA/HRS Focused Update on the Management of Patient With Atrial Fibrillation. A Report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines / L. S. Wann [et al.] // Circulation. - 2011. - Vol. 123. - P. 104-123.ACCF/AHA/HRS Focused Update on the Management of Patient With Atrial Fibrillation. A Report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines / L. S. Wann [et al.] // Circulation. - 2011. - Vol. 123. - P. 104-123.Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale / P. Dorian [et al.] // Circ. Arrhythm. Electrophysiol. - 2009. - Vol. 2. - P. 218-224.Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale / P. Dorian [et al.] // Circ. Arrhythm. Electrophysiol. - 2009. - Vol. 2. - P. 218-224.Hughes, M. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data / M. Hughes, G. Y. Lip // Thromb. Haemost. - 2008. - Vol. 99. - P. 295-304.Hughes, M. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data / M. Hughes, G. Y. Lip // Thromb. Haemost. - 2008. - Vol. 99. - P. 295-304.Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA) / P. Kirchhof [et al.] // Eur Heart J. - 2007. - Vol. 28. - P. 2803-2817.Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA) / P. Kirchhof [et al.] // Eur Heart J. - 2007. - Vol. 28. - P. 2803-2817.Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation / E. M. Hylek [et al.] // N. Engl. J. Med. - 2003. - Vol. 349. - P. 1019-1026.Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation / E. M. Hylek [et al.] // N. Engl. J. Med. - 2003. - Vol. 349. - P. 1019-1026.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation / G. Y. Lip [et al.] // Chest. - 2010. - Vol. 137. - P. 263-272.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation / G. Y. Lip [et al.] // Chest. - 2010. - Vol. 137. - P. 263-272.Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation / R. G. Hart, L. A. Pearce, M.I. Aguilar // Ann. Intern. Med. - 2007. - Vol. 146. - P. 857-867.Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation / R. G. Hart, L. A. Pearce, M.I. Aguilar // Ann. Intern. Med. - 2007. - Vol. 146. - P. 857-867.A novel user-friendly score (HAS-BLED) to assess one year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey / R. Pisters [et al.] // Chest. -2010. - March 18.A novel user-friendly score (HAS-BLED) to assess one year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey / R. Pisters [et al.] // Chest. -2010. - March 18.Stroke in AF working group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review / Neurology. - 2007. - Vol. 69. - P. 546-554.Stroke in AF working group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review / Neurology. - 2007. - Vol. 69. - P. 546-554.Kirchhof, P. Can we improve outcomes in atrial fibrillation patients by early therapy? / P. Kirchhof // B.M.C. Med. - 2009. - Vol. 7. - P. 72.Kirchhof, P. Can we improve outcomes in atrial fibrillation patients by early therapy? / P. Kirchhof // B.M.C. Med. - 2009. - Vol. 7. - P. 72.AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation / N. Engl. J. Med. - 2002. - Vol. 347. - P. 1825-1833.AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation / N. Engl. J. Med. - 2002. - Vol. 347. - P. 1825-1833.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation / I.C. Van Gelder [et al.] // N. Engl. J. Med. - 2002. - Vol. 347. - P. 1834-1840.A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation / I.C. Van Gelder [et al.] // N. Engl. J. Med. - 2002. - Vol. 347. - P. 1834-1840.Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation / J. Carlsson [et al.] // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 1690-1696.Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation / J. Carlsson [et al.] // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 1690-1696.Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study / G. Opolski [et al.] // Chest. - 2004. - Vol. 126. - P. 476-486.Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study / G. Opolski [et al.] // Chest. - 2004. - Vol. 126. - P. 476-486.Rhythm control versus rate control for atrial fibrillation and heart failure / D. Roy [et al.] // N. Engl. J. Med. - 2008. - Vol. 358. - P. 2667-2677.Rhythm control versus rate control for atrial fibrillation and heart failure / D. Roy [et al.] // N. Engl. J. Med. - 2008. - Vol. 358. - P. 2667-2677.Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study / S. Ogawa [et al.] // Circ. J. - 2009. - Vol. 73. - P. 242-248.Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study / S. Ogawa [et al.] // Circ. J. - 2009. - Vol. 73. - P. 242-248.Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? / A. S. Go [et al.]. // JAMA. - 2003. - Vol. 290. - P. 2685-2692.Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? / A. S. Go [et al.]. // JAMA. - 2003. - Vol. 290. - P. 2685-2692.Outpatient treatment of recent-onset atrial fibrillation with the ‘pill-in-the-pocket’ approach / P. Alboni [et al.] // N. Engl. J. Med. - 2004. - Vol. 351. - P. 2384-2391.Outpatient treatment of recent-onset atrial fibrillation with the ‘pill-in-the-pocket’ approach / P. Alboni [et al.] // N. Engl. J. Med. - 2004. - Vol. 351. - P. 2384-2391.Pulmonary-vein isolation for atrial fibrillation in patients with heart failure / M. N. Khan [et al.] // N. Engl. J. Med. - 2008. - Vol. 359. - P. 1778-1785.Pulmonary-vein isolation for atrial fibrillation in patients with heart failure / M. N. Khan [et al.] // N. Engl. J. Med. - 2008. - Vol. 359. - P. 1778-1785.Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation / Goette [et al.] // J. Am. Coll. Cardiol. - 2000. - Vol. 35. - P. 1669-1677.Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation / Goette [et al.] // J. Am. Coll. Cardiol. - 2000. - Vol. 35. - P. 1669-1677.Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial / R. E. Schmieder [et al.] // J. Hypertens. - 2008. - Vol. 26. - P. 403-411.Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial / R. E. Schmieder [et al.] // J. Hypertens. - 2008. - Vol. 26. - P. 403-411.Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study / K. C. Ueng [et al.] // Eur. Heart J. - 2003. - Vol. 24. - P. 2090-2098.Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study / K. C. Ueng [et al.] // Eur. Heart J. - 2003. - Vol. 24. - P. 2090-2098.

The authors declare that there are no conflicts of interest present.